A Phase Ib/II Study of BBI608 in Combination With Pembrolizumab in Patients With Metastatic Colorectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Napabucasin (Primary) ; Pembrolizumab (Primary)
- Indications Colorectal cancer; Gastrointestinal cancer
- Focus Therapeutic Use
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 20 Oct 2016 Status changed from not yet recruiting to recruiting.
- 19 Oct 2016 Planned End Date changed from 1 Mar 2021 to 1 Apr 2021.